Reuters logo
BRIEF-Fennec Pharmaceuticals Q3 loss per share $0.15‍​
November 13, 2017 / 11:08 AM / 10 days ago

BRIEF-Fennec Pharmaceuticals Q3 loss per share $0.15‍​

Nov 13 (Reuters) - Fennec Pharmaceuticals Inc

* Fennec provides business update and reports third quarter 2017 results

* Fennec Pharmaceuticals Inc - qtrly loss per share $0.15‍​

* Fennec Pharmaceuticals Inc - cash and cash equivalents at Sept 30,2017, $9.7 million versus $3.9 million at Dec 31, 2016‍​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below